Condition: Nasopharyngeal Carcinoma · Sponsor: Sun Yat-sen University
The purpose of this study is to explore the efficacy and safety of neoadjuvant GP chemotherapy plus adebrelimab versus neoadjuvant GP chemotherapy in treating high-risk locoregionally advanced nasopharyngeal carcinoma patients.
This description comes directly from the study's public registry record.
Hai-Qiang Mai, MD, PhD · 8613570027338 · maihq@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Foshan First People's Hospital | Foshan, Guangdong, China | Not Yet Recruiting |
| Affiliated cancer hospital and institute of guangzhou medical university | Guangzhou, China | Not Yet Recruiting |
| Sun Yat-Sen Memorial Hospital | Guangzhou, China | Not Yet Recruiting |
| The affiliated panyu central hospital of guangzhou medical university | Guangzhou, China | Not Yet Recruiting |
| ZhuJiang Hospital of Southern Medical University | Guangzhou, China | Not Yet Recruiting |
| Liuzhou Workers Hospital | Liuzhou, China | Not Yet Recruiting |
| Guangxi Medical University Affiliated Cancer Hospital | Nanning, China | Not Yet Recruiting |
| Cancer hospital of Shantou university medical college | Shantou, China | Not Yet Recruiting |
| Cancer hospital Chinese academy of medical sciences, Shenzhen center | Shenzhen, China | Not Yet Recruiting |
| The second people's hospital of Shenzhen | Shenzhen, China | Recruiting |
| The university of Hongkong - Shenzhen hospital | Shenzhen, China | Not Yet Recruiting |
| Guangdong Medical School First Affiliated Hospital | Zhangjiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06455410